“It’s been said that developing a drug is not rocket science, it’s actually much, much harder,” said Dan Skovronsky, MD, PhD and Chief Scientific Officer for Eli Lilly and Company.
In this month’s podcast, you will hear how medicines are discovered and made.
Listen to Dan Skovronsky, MD, PhD and Chief Scientific Officer for Eli Lilly and Company discuss the complicated process of drug discovery and development with his medical school classmate, friend and host of Healthcare Triage podcast, IU School of Medicine faculty member and New York Times contributor Aaron E. Carroll, MD.
IU School of Medicine collaborates with Lilly on a variety of projects, including the IU Grand Challenge Precision Health initiative. During the podcast, Skovronsky shares about the importance of research, his gratitude to patients willing to participate in research and Lilly’s foray into RNA medicines.
The Healthcare Triage podcast is sponsored by Indiana University School of Medicine whose mission is to advance health in the state of Indiana and beyond by promoting innovation and excellence in education, research and patient care.
IU School of Medicine is leading Indiana University's first grand challenge, the Precision Health Initiative, with bold goals to cure multiple myeloma, triple negative breast cancer and childhood sarcoma and prevent type 2 diabetes and Alzheimer’s disease.Listen to the podcast